- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
NCATS Rapid Response Un-Meeting
Moving scientific discoveries into the “real world” effectively, efficiently, and safely are core principles of translational science. With the advent of big data analytics and data derived from multiple sources, it has become increasingly clear that utilizing data from real-world contexts opens another key layer of the translational science process.
The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
The NCATS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help foster small business participation in research and development as well as technology commercialization. These programs are engines of innovation, offering grants, contracts and technical assistance to small businesses and academic research organizations. There are many benefits to
NCATS is conducting a technical assistance webinar on Tuesday, September 28, 2021, from 1:00 – 3:00 PM EDT (12PM CDT, 11AM MDT, 10AM PDT) for applicants responding to the Clinical and Translational Science Award (UM1 Clinical Trial Optional) (PAR-21-293). Registration required: register here. All prospective applicants are invited to attend and are highly encouraged to submit questions at least
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Mathew Cherian MD, from Ohio State University, hosted by the National Center for Advancing Translational Sciences will present his research on "Tolerable Strategies to Overcome Treatment Resistance in Breast Cancer" Resistance to first-line endocrine and cyclin
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Marina Walther-Antonio, PhD from the Mayo Clinic Rochester, hosted by the University of California San Diego will present her research on "The Microbiome Side of Endometrial Cancer.
The Translational Science Interagency Fellowship (TSIF) program is jointly sponsored by NCATS and the U.S. Food and Drug Administration (FDA) and aims to provide training in both translational science and regulatory science. The common goal of NCATS and the FDA is to bring safe and effective drugs, regimens and devices from the bench to the bedside as quickly and efficiently as possible. To that
The Translational Science Interagency Fellowship (TSIF) is a new postdoctoral fellowship opportunity developed by the National Center for Advancing Translational Sciences (NCATS) and the U.S. Food and Drug Administration (FDA). Fellows will be jointly mentored by NCATS and FDA scientists on a research project of mutual interest to both organizations. Fellows in this program will develop skills of
The Center for Clinical & Translational Science will use new grant to help grow the reach of I-Corps@NCATS in order to help scientists translate their discoveries to the marketplace.
The NCATS Advisory Council will convene a virtual meeting on Sept. 17, 2020. The meeting will feature presentations by NCATS leadership and invited guests. For more information about the Advisory Council, visit the NCATS Advisory Council page of this site. Closed Session: 10-11 a.m. ET Open Session: 11:30a.m. to 5 p.m. ET
During this session, participants will learn about the field of translational science, how NCATS is developing this new field of investigation and opportunities to conduct translational science research in the NCATS intramural (i.e., on-site in Maryland) laboratories. NCATS defines translational science as “an emerging field of investigation focused on identifying and understanding broadly
Enhance your translational science skills this summer with a seven-week online course, MEDI 501: Principles of Preclinical Translational Science. This class is open to the public and is being offered by NCATS’ Education Branch in partnership with the Foundation for Advanced Education in the Sciences(link is external). This course has reached capacity for Summer 2020. To receive an invitation to
Join the Ground Rounds Rethinking Clinical Trial Series with guest speakers: Ken Gersing, MD Director of Informatics, NCATS National Institutes of Health Robert A. Star, MD Director, Division of Kidney, Urologic, and Hematologic Disorders, NIDDK Chief, Renal Diagnostics and Therapeutics Unit, NIDDK National Institutes of Health